OGI241115C3000
- 0.05
- 0.000.00%
OrganiGram Newsroom
Microsoft Shares Are Trading Higher After the Company Reported Better-than-expected Q1 2025 GAAP EPS and Sales.
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
How Germany's Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities
Beena Goldenberg, CEO Of Organigram Says, "I Do Think That Long-Term, The [Cannibas] Market Is Going To Move To Less On Combustables, More On Ingestibles"
Banzai Granted Extension By Nasdaq Hearing Panel To Regain Compliance With Listing Requirements
Shares of Cannabis Stocks Are Trading Higher Following a Report Suggesting That Vice President Harris Wants to Legalize Marijuana.
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes
Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls & Vapes As Market Eyes C$5.47B
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Marijuana Stock Movers For September 9, 2024
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
Organigram Closes Second Tranche of BAT Private Placement
Organigram Advances Global Cannabis Strategy With BAT Investment
Organigram Brief: Says Closed Second Tranche of Previously Announced BAT Private Placement Investment
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
American Views on Marijuana Effects Worsening: Gallup
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
Shares of Cannabis Stocks Are Trading Lower After the DEA Announced a Delay on Its Final Ruling on Cannabis Rescheduling Until After the November Presidential Election.
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election